OVB.L - Ovoca Bio plc Stock Price & Dividend Safety Sector: Healthcare | Exchange: London Stock Exchange Current Price & Safety Score Price: 7.30 GBp StockBonds Safety Grade: Altman Z-Score (Bankruptcy Risk): -4.49 StockBond Score: 2.08 Company Description Ovoca Bio plc a clinicalstage biopharmaceutical company engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions It is developing BP101 a medicinal treatment for premenopausal women with hypoactive sexual desire disorder which is in phase II clinical study in Australia and New Zealand and in phase III clinical trials in Russia It also engages in mineral exploration as well as provides support services The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018 Ovoca Bio plc was incorporated in 1985 and is based in Dublin Ireland